MT-1001 (Macrophage Therapeutics)

N/A

Report date: 2025/01/26 15:46:05

Base Information

Drug NameMT-1001 (Macrophage Therapeutics)
Drug Alias NameMT-1000
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionMannose-binding protein C inhibitors
TargetsMannose-binding protein C
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMacrophage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMacrophage Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A